Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to ...
Immunotherapy, a form of cancer treatment that often requires expensive hospital-based injections, may one day be available ...
Gilead may collaborate with Galapagos to develop Ouro's in-licensed gamgertamig for the treatment of B-cell mediated ...
Gilead Sciences has partnered with digital health company Manta Cares to get tools for navigating lung and breast cancer care ...
Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to steer the particles ...
Other companies presented plans to ramp up capabilities for making antibody-drug conjugates (ADCs), a relatively new kind of ...
SHANGHAI and NANJING, China and PLEASANTON, Calif., March 24, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical ...
The Global Virus Network (GVN), a coalition of leading virologists connecting more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and ...
Morning Overview on MSN
New Apogee Therapeutics data reveal long-acting eczema drug cuts flares with fewer shots
Apogee Therapeutics is advancing APG777, an experimental antibody designed to treat moderate-to-severe atopic dermatitis with far fewer injections than existing biologics. Early clinical data show the ...
Morning Overview on MSN
Pfizer, Valneva Lyme vaccine misses primary endpoint despite efficacy
Pfizer and Valneva’s experimental Lyme disease vaccine, VLA15, failed to meet the primary endpoint of its late-stage clinical ...
Objective Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis and primarily affects the joints. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results